Vacuna antiaftosa con antígenos producidos en cultivos celulares con suero tratado por PEG
Foot-and-mouth disease vaccine with antigens produced in cell cultures grown with PEG-treated bovine serum
dc.contributor.author | Mesquita, JA | |
dc.contributor.author | Carneiro, AS | |
dc.date.accessioned | 2019 | |
dc.date.available | 2019 | |
dc.date.issued | 1979 | |
dc.identifier.citation | Mesquita JA, Carneiro AS. Vacuna antiaftosa con antígenos producidos en cultivos celulares con suero tratado por PEG. Bol Cent Panam Fiebre Aftosa. 1979; 33-34: 61. | es_ES |
dc.identifier.citation | Mesquita JA, Carneiro AS. Foot-and-mouth disease vaccine with antigens produced in cell cultures grown with PEG-treated bovine serum. Bol Cent Panam Fiebre Aftosa. 1979; 33-34: 62. | en_US |
dc.identifier.issn | 0009-0131 | |
dc.identifier.uri | https://iris.paho.org/handle/10665.2/51128 | |
dc.description.abstract | Abaracón y Giacometti publicaron el uso experimental satisfactorio de una vacuna antiaftosa elaborada con antígenos producidos en cultivos celulares BHK, en suspensión, en los cuales existía 5,0% de suero bovino al que se habían extraído anticuerpos mediante precipitación com PEG. Sin embargo, como se usó solamente un pequeño número de bovinos, la vacuna fue ensayada otra vez en una mayor población para determinar la posible sensibilidad al mayor contenido de suero que lo usual. | es_ES |
dc.description.abstract | Abaracon and Giacometti reported the sucessful experimental use of a foot-and-mouth disease (FMD) vaccine with antigens produced in suspension cultures of BHK cells grown in the presence of 5.0% bovine serum, from which FMD antibodies had been removed by PEG precipitation. However, since only a small number of cattle had been used, the vaccine was tested again in a large vaccinated population in order to determine the possible sensitivity of the cattle to the higher than usual bovine serum content. | en_US |
dc.language.iso | es | es_ES |
dc.language.iso | en | en_US |
dc.publisher | OPS | es_ES |
dc.relation.ispartofseries | Bol Cent Panam Fiebre Aftosa;33-34 | |
dc.subject | Fiebre Aftosa | es_ES |
dc.subject | Vacunas | es_ES |
dc.subject | Antígenos | es_ES |
dc.subject | Anticuerpos | es_ES |
dc.subject | Serología | es_ES |
dc.subject | Foot-and-Mouth Disease | en_US |
dc.subject | Vaccines | en_US |
dc.subject | Antibodies | en_US |
dc.title | Vacuna antiaftosa con antígenos producidos en cultivos celulares con suero tratado por PEG | es_ES |
dc.title | Foot-and-mouth disease vaccine with antigens produced in cell cultures grown with PEG-treated bovine serum | en_US |
dc.type | Journal articles | en_US |
dc.rights.holder | Pan American Health Organization | en_US |
dc.contributor.corporatename | Organización Panamericana de la Salud | es_ES |
paho.isfeatured | 0 | en_US |
paho.publisher.country | Brazil | en_US |
paho.publisher.city | Rio de Janeiro | en_US |
paho.source.centercode | BR680.1 | en_US |
paho.contributor.department | Centro Panamericano de Fiebre Aftosa y Salud Pública Veterinaria (PANAFTOSA) |